Showing results (71-80 of 83) with videos related to
Sort By:
Pageof 9
Blood Cancer Journal|November 15, 2014
Ofatumumab and high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemiaJ E Castro, M Y Choi, T Carvajal, et al.American Journal of Clinical Pathology|July 1, 1986
COTA (colon-ovarian tumor antigen). An immunohistochemical studyK D Pant, C M Fenoglio-Preiser, C O Berry, et al.Diseases of the Colon and Rectum|April 1, 1980
Colonic tumorigenesis in rats with 1,2-dimethylhydrazineP F Hagihara, K Yoneda, C R Sachatello, et al.British Journal of Industrial Medicine|February 1, 1983
Histocompatibility antigens in coal miners with pneumoconiosisC A Soutar, I Coutts, W R Parkes, et al.Leukemia|August 21, 2009
Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemiaJ E Castro, D F James, J D Sandoval-Sus, et al.Leukemia|October 1, 2010
A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154W G Wierda, J E Castro, R Aguillon, et al.Immunity|December 1, 1996
Fas modulation of apoptosis during negative selection of thymocytesJ E Castro, J A Listman, B A Jacobson, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 22, 2009
Brain metastases from prostate adenocarcinomaJ E Castro Gómez, U Anido Herranz, A Carballo Castro, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1984
Characterization of a common antigen of colorectal and mucinous ovarian tumors, COTAK D Pant, P O Zamora, B A Rhodes, et al.Leukemia|February 25, 2006
Thymidine-phosphorothioate oligonucleotides induce activation and apoptosis of CLL cells independently of CpG motifs or BCL-2 gene interferenceJ E Castro, C E Prada, R A Aguillon, et al.Pageof 9